Аллергические болезни: дифференциальный диагноз, лечение - [99]
Riise G.S. Bacterial colonization in chronic bronchitis and COPD // P. News. 1997. № 1. P. 13–15.
Rrteid A., Andersson P., Edsbacker S. et al. Pharmacokinetics and methabolism of budesonide a selective glucocorticoud // Europ. J. Respir. Dis. 1982. V. 63, Suppl. 122. P 86–95.
Scordamagia A. et al. Theophilline and immunae response: in vitro and in vivo effects // Clin. Immunol, and Immunopathol. 1988. V. 48. P. 238–246.
Siafacas N.M. et al. Optimal assessment and management of chronic obstructive pulmonary diseases (copd) // Eur. Resp. J. 1995. P. 1398–1420.
Staquet M.J. et al. Lofatadine down regulates ICAM-I expression on human keratinocytes and Langerhans cell // Europ. J. Dermatol. 1996. V. 6. P. 369–372.
Stolte М., Heilmann K. Neue klassifikation und Gradierung der Gastritis // Leber, Magen, Darm. 1989. Bd 5. S. 220–226.
Teisberg P. et al. Complement system studies in adult caeliac disease // Scandina vian Journal of Gastroenterology. 1977. V. 12. P. 873–876.
Temple D.M., McCluskey M. Loratadine, an antihistamine, blocks antigenand ionoforeinduced leukotriene release from human lung in vitro// Prostaglandins. 1988. V. 35„P. 549–553.
Valerie J. et al. Отчет о Международном консенсусе по диагностике и лечению ринита // Рос. ринология. 1996. № 4.
Vignola A.M. et al. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-I and HLA-Dr by nasal epithelial cells // Allergy. 1995. V. 50. P. 200–203.
* * *
